Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Raw Materials: 2021-2024

Historic Raw Materials for Veracyte (VCYT) over the last 4 years, with Dec 2024 value amounting to $17.9 million.

  • Veracyte's Raw Materials rose 25.60% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 25.60%. This contributed to the annual value of $17.9 million for FY2024, which is 346.90% up from last year.
  • As of FY2024, Veracyte's Raw Materials stood at $17.9 million, which was up 346.90% from $4.0 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Raw Materials peaked at $17.9 million during FY2024, and registered a low of $3.0 million during FY2021.
  • Moreover, its 3-year median value for Raw Materials was $4.1 million (2022), whereas its average is $8.7 million.
  • Its Raw Materials has fluctuated over the past 5 years, first dropped by 2.44% in 2023, then surged by 346.90% in 2024.
  • Veracyte's Raw Materials (Yearly) stood at $3.0 million in 2021, then surged by 36.67% to $4.1 million in 2022, then fell by 2.44% to $4.0 million in 2023, then skyrocketed by 346.90% to $17.9 million in 2024.